Wed, Sep 24, 2014, 1:06 AM EDT - U.S. Markets open in 8 hrs 24 mins


% | $
Quotes you view appear here for quick access.

Ohr Pharmaceutical, Inc. Message Board

  • gs88gs88 gs88gs88 May 30, 2013 2:09 PM Flag


    Livermore and others. I watched the Jefferies presentation today and it was a good summary. Possibly, the biggest thing I learned was at the 4:00 mark. CEO mentioned Trodusquemine was undergoing pre-clinical research with "an academic partner" and they have come up with "interesting results" and information will come out on this, "in due time".

    Is this new information (or just new to me?). It would be very nice to have another good product after squalamine.

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • yes, trodusquemine is much bigger than squalamine potentially if they can deliver enough of it via a nose spray or even eye drop, avoiding an IV. It blocks ptp-1b, which inhibits leptin receptors in the hypothalamus, thus restoring the receptor and therefore restorning the bodies response to lepin. Weight loss can be achieved without affecting energy and lipid levels normalized as well.

7.24-0.03(-0.41%)Sep 23 3:59 PMEDT

Trending Tickers

Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.